Altered corticomotor representation in patients with Parkinson's disease

被引:11
|
作者
Kagerer, FA
Summers, JJ
Byblow, WD
Taylor, B
机构
[1] Univ Tasmania, Sch Psychol, Human Motor Control Lab, Hobart, Tas, Australia
[2] Univ Auckland, Dept Exercise & Sport Sci, Human Motor Control Lab, Auckland 1, New Zealand
[3] Royal Hobart Hosp, Dept Neurol, Hobart, Tas, Australia
关键词
D O I
10.1002/mds.10452
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In 6 patients with Parkinson's disease (PD) and 6 age-matched controls, transcranial magnetic stimulation was applied at 56 regions over the motor cortex and premotor cortex of each hemisphere, with the first dorsal interosseous (FDI) muscle of both hands activated at 15% maximum voluntary contraction during stimulation. For each site, motor evoked potential (MEP) landmarks were recovered, including MEP amplitude, MEP onset latency, and silent period duration. Scaled MEP amplitudes were used to construct individual cortical maps of the FDI muscles. The maps revealed an anterior displacement of the muscle representation in PD patients. This anterior shift over motor cortical areas may reflect increased contributions of corticocortical connections between motor cortex and premotor cortical areas, possibly enhanced by the visual feedback aspect of the task. These alterations may reflect adaptations to the impairments in striatocortical circuits in PD. (C) 2003 Movement Disorder Society.
引用
下载
收藏
页码:919 / 927
页数:9
相关论文
共 50 条
  • [1] Asymmetric corticomotor excitability correlations in early Parkinson's disease
    Wu, Allan D.
    Petzinger, Giselle M.
    Lin, Chien-Ho J.
    Kung, Myron
    Fisher, Beth
    MOVEMENT DISORDERS, 2007, 22 (11) : 1587 - 1593
  • [2] OLFACTORY SNIFFING IS ALTERED IN PATIENTS WITH PARKINSON'S DISEASE
    Andelman-Gur, Michal
    Hezi, Neomi
    Ezra, Adi
    Gurevich, Tanya
    Sobel, Noam
    CHEMICAL SENSES, 2023, 48
  • [3] Olfactory Sniffing is Altered in Patients with Parkinson's Disease
    Andelman-Gur, M.
    Hezi, N.
    Ezra, A.
    Zitser, J.
    Gurevich, T.
    Sobel, N.
    MOVEMENT DISORDERS, 2023, 38 : S179 - S179
  • [4] Altered caffeine metabolism in patients with Parkinson's disease
    Forsyth, J
    Grünewald, RA
    Lennard, MS
    Rostami-Hodjegan, A
    Sagar, HJ
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (05) : 579 - 580
  • [5] Corticomotor excitability in drug-naive patients with Parkinson disease
    Derejko, Miroslawa
    Rakowicz, Maria
    Antczak, Jakub
    Inglot, Ewa
    Niewiadomska, Maria
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2013, 47 (02) : 109 - 115
  • [6] Altered emotional recognition and expression in patients with Parkinson's disease
    Jin, Yazhou
    Mao, Zhiqi
    Ling, Zhipei
    Xu, Xin
    Zhang, Zhiyuan
    Yu, Xinguang
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2891 - 2902
  • [7] Knowledge representation of motor activity of patients with Parkinson's disease
    Kostek, Bozena
    Kupryjanow, Adam
    Czyzewski, Andrzej
    NATURAL COMPUTING, 2015, 14 (04) : 579 - 591
  • [8] Knowledge representation of motor activity of patients with Parkinson’s disease
    Bożena Kostek
    Adam Kupryjanow
    Andrzej Czyżewski
    Natural Computing, 2015, 14 : 579 - 591
  • [9] Altered chemosenses in Parkinson's Disease
    Muhammed, N.
    Deeb, J.
    Shah, M.
    Findley, L.
    Hawkes, C. H.
    CHEMICAL SENSES, 2006, 31 (05) : A107 - A107
  • [10] Relationship between balance performance and corticomotor Inhibition in individuals with Parkinson's disease
    Liu, H. H.
    Yang, Y. R.
    Ling, Y. L.
    Wang, R. Y.
    Cheng, S. J.
    MOVEMENT DISORDERS, 2023, 38 : S542 - S542